Skip to main content
. 2018 Oct 15;8:15229. doi: 10.1038/s41598-018-33449-0

Figure 2.

Figure 2

Unknown metabolites 1–6 differentiate CLN2 disease subjects from normal controls. (ag) MS signal abundances of unknown metabolites 1–6 are decreased in the CLN2 disease group versus normal controls (p < 0.05, see Table 1 for details). Indicated signal abundances were quantified as areas under their cognate chromatographic peaks. h, Linear correlation of MS signal abundances of Unknown 4 with a co-eluting metabolite feature of 139.981 Da (Pearson correlation r > 0.85, p < 0.0001), indicating a relationship as a precursor and in-source fragment ion.